STEPHEN D. ROBERTS, PH.D.
This content is PDF only. Please click on the PDF icon to access.
When the outcome of a clinical trial shows that one treatment increases survival over alternative therapies, the result may be expected to establish a new standard of medical practice, particularly if the trial involves multiple clinical sites with a large number of patients and is conducted by a prominent group of investigators. The trial of continuous versus nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease, reported in this issue (1), may set such a standard of care. The study concludes that patients with hypoxemic chronic obstructive lung disease, particularly those with more severe derangements of lung and brain function
ROBERTS SD. Cost-Effective Oxygen Therapy. Ann Intern Med. 1980;93:499–500. doi: https://doi.org/10.7326/0003-4819-93-3-499
Download citation file:
Published: Ann Intern Med. 1980;93(3):499-500.
Healthcare Delivery and Policy, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use